Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-Stage Kidney Failure Patients

This study is ongoing, but not recruiting participants.

Study NCT00426712 Information provided by Dynavax Technologies Corporation

First Received: January 23, 2007 Last Updated: January 22, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2008
Estimated Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)